Latest Ratios: P/E Ratio 39.7x · EV/EBITDA 15.5x · ROE 4.6%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $14.5B | $14.0B | $21.0B | $15.5B | $13.6B | $20.8B | $15.8B | $14.6B | $12.8B | $11.9B | $8.6B |
| Enterprise Value | $17.1B | $16.7B | $23.5B | $18.0B | $16.2B | $22.2B | $17.8B | $16.3B | $14.8B | $13.0B | $9.9B |
| P/E Ratio → | 39.68 | 37.39 | 53.41 | 52.66 | 35.23 | 1.76 | 16.58 | 7.81 | 22.98 | 7.99 | 7.87 |
| P/S Ratio | 3.54 | 3.42 | 5.39 | 4.32 | 4.11 | 7.11 | 6.50 | 5.49 | 5.07 | 5.57 | 4.39 |
| P/B Ratio | 1.80 | 1.70 | 2.60 | 2.06 | 1.89 | 2.99 | 4.13 | 4.01 | 3.88 | 3.75 | 3.20 |
| P/FCF | 33.37 | 32.24 | 72.81 | 72.21 | 30.17 | 39.65 | 89.72 | 34.59 | 27.01 | 25.55 | 24.16 |
| P/OCF | 18.18 | 17.56 | 29.58 | 25.56 | 19.62 | 28.14 | 32.49 | 20.42 | 19.19 | 20.07 | 16.93 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.07 | 6.02 | 5.00 | 4.90 | 7.59 | 7.30 | 6.14 | 5.84 | 6.08 | 5.01 |
| EV / EBITDA | 15.50 | 15.06 | 21.70 | 19.95 | 18.99 | 27.20 | 29.65 | 19.70 | 21.80 | 21.05 | 18.87 |
| EV / EBIT | 25.11 | 26.42 | 33.67 | 34.69 | 30.44 | 43.08 | 58.54 | 29.89 | 35.66 | 30.42 | 30.64 |
| EV / FCF | — | 38.40 | 81.41 | 83.60 | 36.00 | 42.29 | 100.77 | 38.71 | 31.10 | 27.87 | 27.62 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.7% | 60.7% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.4% | 63.9% | 59.6% |
| Operating Margin | 16.7% | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% |
| Net Profit Margin | 9.2% | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.6% | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.5% | 4.3% | 12.7% | 10.2% |
| ROA | 3.0% | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.6% | 8.0% | 6.1% |
| ROIC | 4.8% | 4.8% | 5.1% | 4.0% | 4.2% | 5.4% | 4.2% | 7.7% | 6.4% | 7.9% | 6.1% |
| ROCE | 6.1% | 6.1% | 6.4% | 5.1% | 5.3% | 6.9% | 5.7% | 10.2% | 8.0% | 10.2% | 8.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.32 | 0.34 | 0.39 | 0.21 | 0.54 | 0.50 | 0.61 | 0.37 | 0.49 |
| Debt / EBITDA | 2.52 | 2.52 | 2.39 | 2.85 | 3.24 | 1.82 | 3.45 | 2.21 | 2.98 | 1.90 | 2.55 |
| Net Debt / Equity | — | 0.32 | 0.31 | 0.32 | 0.37 | 0.20 | 0.51 | 0.48 | 0.59 | 0.34 | 0.46 |
| Net Debt / EBITDA | 2.42 | 2.42 | 2.29 | 2.72 | 3.08 | 1.70 | 3.25 | 2.10 | 2.87 | 1.76 | 2.36 |
| Debt / FCF | — | 6.16 | 8.59 | 11.39 | 5.83 | 2.64 | 11.05 | 4.13 | 4.09 | 2.32 | 3.45 |
| Interest Coverage | 6.30 | 6.30 | 6.09 | 4.92 | 9.29 | 22.28 | 8.24 | 8.02 | 5.01 | 12.80 | 12.29 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.89 | 1.89 | 1.91 | 1.76 | 1.20 | 2.00 | 1.27 | 1.05 | 2.03 | 2.41 | 1.74 |
| Quick Ratio | 1.13 | 1.13 | 1.12 | 1.00 | 0.71 | 1.20 | 0.70 | 0.59 | 1.16 | 1.26 | 0.96 |
| Cash Ratio | 0.10 | 0.10 | 0.11 | 0.12 | 0.11 | 0.13 | 0.12 | 0.08 | 0.14 | 0.22 | 0.19 |
| Asset Turnover | — | 0.33 | 0.32 | 0.31 | 0.29 | 0.30 | 0.36 | 0.42 | 0.41 | 0.44 | 0.44 |
| Inventory Turnover | 1.90 | 1.90 | 1.62 | 1.68 | 1.86 | 1.65 | 1.57 | 1.77 | 1.92 | 1.70 | 1.90 |
| Days Sales Outstanding | — | 73.94 | 67.18 | 61.93 | 61.54 | 64.36 | 65.38 | 59.88 | 54.00 | 54.02 | 54.08 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Payout Ratio | — | — | — | 1.0% | 0.8% | 0.1% | 1.3% | 0.6% | 2.1% | 0.8% | 1.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.5% | 2.7% | 1.9% | 1.9% | 2.8% | 56.7% | 6.0% | 12.8% | 4.4% | 12.5% | 12.7% |
| FCF Yield | 3.0% | 3.1% | 1.4% | 1.4% | 3.3% | 2.5% | 1.1% | 2.9% | 3.7% | 3.9% | 4.1% |
| Buyback Yield | 2.0% | 2.1% | 0.0% | 0.0% | 0.6% | 0.1% | 0.3% | 1.1% | 0.0% | 0.5% | 0.0% |
| Total Shareholder Yield | 2.0% | 2.1% | 0.0% | 0.0% | 0.6% | 0.1% | 0.3% | 1.1% | 0.0% | 0.5% | 0.0% |
| Shares Outstanding | — | $200M | $200M | $199M | $199M | $199M | $198M | $200M | $199M | $198M | $196M |
Operating margin volatility
According to current market data, COO trades at a trailing P/E of 37.98, which appears elevated relative to its recent earnings instability and suggests that investors are pricing in a recovery in profitability rather than reflecting the company's current, more constrained bottom-line performance metrics.
The forward P/E of 15.34 indicates that the market anticipates a significant rebound in earnings, likely driven by the scaling of myopia management products. However, this valuation premium remains sensitive to the company's ability to control rising SG&A expenses, which have recently pressured net margins and obscured the underlying growth trajectory.
As reported in financial statements, ROIC has trended downward to -0.2% in 2026Q2, a sharp reversal from historical levels that highlights the difficulty of maintaining efficient capital deployment while absorbing the integration costs associated with the firm's aggressive, acquisition-heavy growth strategy in the surgical segment.
The decline in ROIC suggests that the company's recent investments are not yet generating sufficient returns to cover the cost of capital. Investors should monitor whether this is a temporary byproduct of recent M&A activity or a structural deterioration in the profitability of the core CooperVision and CooperSurgical business units.
Based on the latest quarterly data, the cash conversion cycle has expanded to 235 days, driven largely by elevated days inventory outstanding of 228, which suggests that the company is struggling to optimize its supply chain and manage the high-SKU complexity inherent in its specialty lens portfolio.
The persistent length of the cash conversion cycle indicates that a significant amount of capital is tied up in inventory, which may be a strategic necessity for maintaining high service levels for optometrists but nonetheless limits free cash flow generation. This inefficiency warrants further investigation into whether inventory management processes can be streamlined without compromising the firm's competitive moat.
As indicated by recent filings, the company maintains a stable debt-to-equity ratio of 0.30, demonstrating a disciplined approach to capital structure that provides a necessary buffer against the recent volatility in operating income and the potential for further debt-funded acquisitions in the medical device space.
While the low leverage profile is a positive indicator of financial health, the recent decline in interest coverage to -1.32 in 2026Q2 suggests that the company's ability to service debt from operating income is currently under pressure. This warrants close monitoring to ensure that the firm's financial flexibility is not compromised by sustained operating losses.
The P/E ratio is frequently misapplied to COO, as it fails to account for the significant non-cash amortization of intangible assets resulting from the firm's 'string-of-pearls' acquisition strategy, which systematically suppresses reported GAAP earnings and obscures the company's true underlying cash-generating capacity and operational performance.
Analysts should prioritize EV/EBITDA or P/FCF metrics to better evaluate the company's performance, as these measures are less distorted by the accounting treatment of acquisitions. Relying solely on P/E may lead to an inaccurate assessment of the company's valuation, as it ignores the recurring nature of the vision segment's cash flows.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying COO stock.
The Cooper Companies, Inc.'s current P/E ratio is 39.7x. The historical average is 11.8x. This places it at the 93th percentile of its historical range.
The Cooper Companies, Inc.'s current EV/EBITDA is 15.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.8x.
The Cooper Companies, Inc.'s return on equity (ROE) is 4.6%. The historical average is 21.2%.
Based on historical data, The Cooper Companies, Inc. is trading at a P/E of 39.7x. This is at the 93th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Cooper Companies, Inc. has 60.7% gross margin and 16.7% operating margin. Operating margin between 10-20% is typical for established companies.
The Cooper Companies, Inc.'s Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.